Alteplase: Clinical Trials

91 trials of Alteplase, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

50 completed, 12 unknown, 9 terminated, 8 recruiting. 35 Phase 3, 20 Phase 2, 13 Phase 4, 9 Not applicable, 2 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 335Completed 20, Terminated 5, Withdrawn 4, Recruiting 3, Unknown 2, Active not recruiting 1
Phase 220Completed 11, Unknown 4, Terminated 2, Withdrawn 2, Recruiting 1
Phase 413Completed 7, Not yet recruiting 2, Terminated 2, Active not recruiting 1, Recruiting 1
Not applicable9Completed 5, Unknown 2, Active not recruiting 1, Terminated 1
Phase 12Terminated 1, Withdrawn 1
Early Phase 11Recruiting 1

Follow Alteplase: new trials by email Literature Review of Alteplase trials Research Report on Alteplase

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
INtra-arterial AltEplase folloWing successfuL reperfusIoN After mEchanical Thrombectomy
Alteplase, Endovascular thrombectomy - Stroke, Acute Ischemic, Large Vessel Occlusion
Phase 3Recruiting115 People's Hospital4162026-08-012026-09-25
Flush, Lyse, Operate
Intrapleural Saline with possible escalation to intraplerual alteplase and dornase. - Complicated Parapneumonic Effusion, Empyema, Pleural
Phase 4Not yet recruitingDartmouth-Hitchcock Medical Center302026-04-012026-05-18
Efficacy and Safety of Tenecteplase Bridging Mechanical Thrombectomy for Acute Large Vessel Occlusion Stroke
Tenecteplase, Alteplase - Stroke, Ischemic, Stroke, Acute
Phase 3RecruitingXuanwu Hospital, Beijing8502025-12-252026-04-09
Reperfusion Treatment in Acute Pulmonary Embolism
Catheter directed intervention, any device, Alteplase - Pulmonary Embolism
RecruitingSahlgrenska University Hospital2202025-04-012026-01-21
Thrombolysis in Factor Xa-inhibitors Trial
thrombolysis therapy - Stroke, Stroke (in Patients With Atrial Fibrillation)
Phase 3RecruitingGuri Hagberg3002025-03-142026-09-23
Endovascular Treatment or Standard Medical Care for Cerebral Venous Sinus Thrombosis(ESCORT)
Heparin, Endovascular treatment - Cerebral Venous Sinus Thrombosis
Not applicableActive not recruitingBeijing Tiantan Hospital2242024-12-242026-08-21
To Compare the Efficacy & Safety of Ultra-Slow (24 hr) Low Dose (25 mg) Infusion of Alteplase Over Slow (24hr) Infusion of Streptokinase in Mechanical Prosthetic Valve Thrombosis
Alteplase, streptokinase - Thrombolysed
Not applicableCompletedU. N. Mehta Institute of Cardiology and Research Center1002024-11-012026-01-26
Trial of Reduced Alteplase Dose for Parapneumonic Effusion (TRAPPE)
Tissue Plasminogen Activator - Pleural Infection
Phase 2 / Phase 3CompletedChinese University of Hong Kong302024-11-012026-10-23
A Real-world Study of Tenecteplase Versus Alteplase for Thrombolysis in Patients Within 4.5 H of Onset of Ischemic Stroke
Tenecteplase, Alteplase - Stroke Acute, Tenecteplase
UnknownTianjin Huanhu Hospital60002024-10-262024-10-29
Treatment of Acute Ischemic StroKe With Intravenous UroKinase Real-world Research: a Multicenter, Prospective Study
Urokinase, Alteplase - Acute Ischemic Stroke
RecruitingThe First Affiliated Hospital of Zhengzhou University18002023-12-302024-01-08
Alteplase Through an Indwelling Pleural Catheter for the Management of Symptomatic Septated Malignant Pleural Effusion
Alteplase, Placebo Administration - Hematopoietic and Lymphoid Cell Neoplasm, Malignant Solid Neoplasm
Early Phase 1RecruitingM.D. Anderson Cancer Center302023-08-172026-08-17
Intra-arterial Alteplase for Acute Ischemic Stroke After Mechanical Thrombectomy
Alteplase - Stroke, Acute Ischemic
Phase 3CompletedSun Yat-Sen Memorial Hospital of Sun Yat-Sen University3242023-08-012026-08-12
Aspirin Combined With Clopidogrel Versus Intravenous Alteplase for Acute Minor Stroke
Aspirin, Clopidogrel, Alteplase - Ischemic Stroke
Phase 4Not yet recruitingSun Yat-Sen Memorial Hospital of Sun Yat-Sen University4722023-07-012023-06-18
Dual IntraVenous Thrombolysis Approach (DIVA) in Patients With Medium-vessel-occlusion Strokes: a Retrospective Study
alteplase, Alteplase + possible complementary IVT with tenecteplase - Acute Ischemic Stroke Due to Medium-vessel-occlusion
CompletedCentre Hospitalier Sud Francilien2942023-05-172023-11-07
Tenecteplase Thrombolytic Therapy for Acute Ischemic Stroke in China
Tenecteplase, Alteplase - Ischemic Stroke
UnknownHuashan Hospital12002023-04-022023-10-12
Mechanical Thrombectomy With the FlowTriever Device in Acute Pulmonary Embolism - a Retrospective Analysis
Mechanical thrombectomy, Intravenous thrombolysis - Pulmonary Embolism
CompletedKristina Svennerholm1322023-04-012025-05-20
Alteplase in Elderly Acute Ischemic Stroke (AIS) Patients During Hospitalization
rt-PA - Stroke
CompletedBoehringer Ingelheim1130352022-11-302024-12-20
Thrombolysis Treated With TNK-tPA in Acute Ischemic Stroke Patients (3T Stroke-Ⅲ)
Alteplase, Tenecteplase - Acute Ischemic Stroke
Phase 3UnknownBeijing Tiantan Hospital16302022-10-262023-02-27
the Predictors of Hemorrhagic Transformation Subtypes in Acute Embolic Stroke Patients
Alteplase - Ischemic Stroke, Alteplase Adverse Reaction
Phase 4RecruitingKafrelsheikh University7162022-07-012024-10-29
Viscoelastic Testing Guided Tissue Plasminogen Activator Treatment in Acute Respiratory Failure
Alteplase - Acute Respiratory Failure, Hypercoagulability
Phase 2RecruitingSouth West Sydney Local Health District702022-05-182024-04-17

Showing 20 of 91. Sign in to see all of them.

Conditions studied

Ischemic Stroke (29)  ·  Stroke (24)  ·  Pulmonary Embolism (8)  ·  Thrombosis (6)  ·  Myocardial Infarction (4)  ·  ST Elevation Myocardial Infarction (4)  ·  Cerebral Infarction (3)  ·  Intracranial Hemorrhages (3)  ·  Intracranial Thrombosis (3)  ·  Postthrombotic Syndrome (3)  ·  Venous Thrombosis (3)  ·  Bites and Stings (2)  ·  Brain Ischemia (2)  ·  Empyema (2)  ·  Ventricular Dysfunction, Right (2)

Sponsors

Boehringer Ingelheim (7)  ·  Beijing Tiantan Hospital (3)  ·  General Hospital of Shenyang Military Region (3)  ·  Johns Hopkins University (3)  ·  Kafrelsheikh University (3)  ·  NHS Greater Glasgow and Clyde (3)  ·  Boston Scientific Corporation (2)  ·  Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University (2)  ·  Supergene, LLC (2)  ·  Tanabe Pharma Corporation (2)  ·  Tasly Biopharmaceuticals Co., Ltd. (2)  ·  115 People's Hospital (1)  ·  Angde Biotech Pharmaceutical Co., Ltd. (1)  ·  Assistance Publique - Hôpitaux de Paris (1)  ·  Assiut University (1)

Countries

China (25)  ·  United States (23)  ·  Canada (8)  ·  United Kingdom (7)  ·  France (5)  ·  Spain (5)  ·  Sweden (5)  ·  Denmark (4)  ·  Egypt (4)  ·  Germany (4)  ·  Australia (3)  ·  Belgium (3)  ·  Israel (3)  ·  Netherlands (3)  ·  Norway (3)

Top investigators

Daniel F. Hanley, MD (2)  ·  Sergey S Markin, MD, PhD (2)  ·  Shuya Li (2)  ·  Yamei Tang (2)  ·  Aaron S Weinberg, MD (1)  ·  Ahmed Hamdy, Ass.Prof (1)  ·  Albert Kadri, MD (1)  ·  Alberto Conti, MD (1)  ·  Alexander I Kirienko, MD, PhD (1)  ·  Anders Aneman (1)  ·  Andrew D Barreto, MD (1)  ·  Asger Andersen, MD, PhD (1)  ·  Azhar Supariwala, MD (1)  ·  Barry S Weinstock, MD (1)

Results publications

PMID 12221155, PMID 16731270, PMID 34515113, PMID 22435369, PMID 25726502, PMID 26387127, PMID 28780236, PMID 29694815, PMID 36446950, PMID 37830342, PMID 39500603, PMID 10591382, PMID 11546885, PMID 12917889, PMID 16574919, PMID 16763187, PMID 18705914, PMID 18815396, PMID 19233036, PMID 20047905, PMID 20075341, PMID 20185783, PMID 20651267, PMID 21030700, PMID 21737309, PMID 22015331, PMID 22340437, PMID 23264523, PMID 23418571, PMID 23493340, PMID 23537968, PMID 24298176, PMID 25212800, PMID 25628404, PMID 25638754, PMID 26243227, PMID 26315743, PMID 26514192, PMID 26763281, PMID 27273860, PMID 27756804, PMID 27913777, PMID 27965285, PMID 28081952, PMID 28174327, PMID 28425349, PMID 28842449, PMID 28844990, PMID 28887375, PMID 28928186

NIH funding

2018 (2), 2019 (1), 2023 (1), U01HL088476 (1), U01NS062851 (1), U01NS080824 (1)